ACADIA Pharmaceuticals Stock Forecast - Naive Prediction

ACAD Stock  USD 17.14  0.27  1.55%   
The Naive Prediction forecasted value of ACADIA Pharmaceuticals on the next trading day is expected to be 17.69 with a mean absolute deviation of  0.70  and the sum of the absolute errors of 42.87. ACADIA Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ACADIA Pharmaceuticals stock prices and determine the direction of ACADIA Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ACADIA Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although ACADIA Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ACADIA Pharmaceuticals' systematic risk associated with finding meaningful patterns of ACADIA Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of ACADIA Pharmaceuticals to cross-verify your projections.
For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.
  
At present, ACADIA Pharmaceuticals' Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 15.93, whereas Receivables Turnover is forecasted to decline to 4.63. . The current year's Common Stock Shares Outstanding is expected to grow to about 172 M, whereas Net Loss is forecasted to decline to (204.1 M).

Open Interest Against 2024-04-19 ACADIA Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast ACADIA Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ACADIA Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ACADIA Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ACADIA Pharmaceuticals' open interest, investors have to compare it to ACADIA Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ACADIA Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ACADIA. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in ACADIA Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the ACADIA Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets ACADIA Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for ACADIA Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of ACADIA Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

ACADIA Pharmaceuticals Naive Prediction Price Forecast For the 17th of April 2024

Given 90 days horizon, the Naive Prediction forecasted value of ACADIA Pharmaceuticals on the next trading day is expected to be 17.69 with a mean absolute deviation of 0.70, mean absolute percentage error of 0.72, and the sum of the absolute errors of 42.87.
Please note that although there have been many attempts to predict ACADIA Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ACADIA Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ACADIA Pharmaceuticals Stock Forecast Pattern

Backtest ACADIA PharmaceuticalsACADIA Pharmaceuticals Price PredictionBuy or Sell Advice 

ACADIA Pharmaceuticals Forecasted Value

In the context of forecasting ACADIA Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ACADIA Pharmaceuticals' downside and upside margins for the forecasting period are 14.59 and 20.80, respectively. We have considered ACADIA Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
17.14
17.69
Expected Value
20.80
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of ACADIA Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent ACADIA Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria117.7815
BiasArithmetic mean of the errors None
MADMean absolute deviation0.7028
MAPEMean absolute percentage error0.0315
SAESum of the absolute errors42.8731
This model is not at all useful as a medium-long range forecasting tool of ACADIA Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict ACADIA Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for ACADIA Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ACADIA Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ACADIA Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.2617.3720.48
Details
Intrinsic
Valuation
LowRealHigh
15.4320.5723.68
Details
20 Analysts
Consensus
LowTargetHigh
28.4431.2534.69
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.080.050.17
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ACADIA Pharmaceuticals. Your research has to be compared to or analyzed against ACADIA Pharmaceuticals' peers to derive any actionable benefits. When done correctly, ACADIA Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ACADIA Pharmaceuticals.

Other Forecasting Options for ACADIA Pharmaceuticals

For every potential investor in ACADIA, whether a beginner or expert, ACADIA Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ACADIA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ACADIA. Basic forecasting techniques help filter out the noise by identifying ACADIA Pharmaceuticals' price trends.

View ACADIA Pharmaceuticals Related Equities

 Risk & Return  Correlation

ACADIA Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ACADIA Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ACADIA Pharmaceuticals' current price.

ACADIA Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how ACADIA Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ACADIA Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying ACADIA Pharmaceuticals stock market strength indicators, traders can identify ACADIA Pharmaceuticals entry and exit signals to maximize returns.

ACADIA Pharmaceuticals Risk Indicators

The analysis of ACADIA Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ACADIA Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting acadia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with ACADIA Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACADIA Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with ACADIA Stock

  0.8VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr

Moving against ACADIA Stock

  0.89RZLT Rezolute TrendingPairCorr
  0.86CELC Celcuity LLC Financial Report 20th of May 2024 PairCorr
  0.82INDP Indaptus Therapeutics Financial Report 9th of May 2024 PairCorr
  0.79NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.57BMY Bristol Myers Squibb Financial Report 25th of April 2024 PairCorr
The ability to find closely correlated positions to ACADIA Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ACADIA Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ACADIA Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ACADIA Pharmaceuticals to buy it.
The correlation of ACADIA Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ACADIA Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ACADIA Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ACADIA Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ACADIA Pharmaceuticals is a strong investment it is important to analyze ACADIA Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ACADIA Pharmaceuticals' future performance. For an informed investment choice regarding ACADIA Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of ACADIA Pharmaceuticals to cross-verify your projections.
For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.
Note that the ACADIA Pharmaceuticals information on this page should be used as a complementary analysis to other ACADIA Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for ACADIA Stock analysis

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is ACADIA Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
4.434
Quarterly Revenue Growth
0.693
Return On Assets
(0.07)
Return On Equity
(0.15)
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.